Solid Biosciences LLC
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $4,736 | $0 |
Gross Profit | -1,235 | -327 | 4,149 | -588 |
EBITDA | -27,788 | -26,535 | -21,678 | -23,114 |
EBIT | -29,023 | -26,862 | -22,265 | -23,702 |
Net Income | -25,072 | -24,303 | -20,336 | -20,980 |
Net Change In Cash | 0 | 0 | 4,736 | 0 |
Free Cash Flow | -21,753 | -25,341 | -20,913 | -18,280 |
Cash | 95,854 | 117,574 | 74,015 | 49,037 |
Basic Shares | 40,934 | 38,155 | 20,386 | 20,059 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $8,094 | $13,620 | $3,335 |
Gross Profit | -76,563 | 5,686 | -45,119 | -3,922 |
EBITDA | -101,734 | -107,924 | -69,290 | -80,597 |
EBIT | -104,315 | -110,332 | -72,254 | -84,519 |
Net Income | -96,015 | -65,510 | -72,124 | -90,118 |
Net Change In Cash | 0 | 8,094 | 13,620 | 3,335 |
Cost of Revenue | 36,011 | -33,865 | 78,701 | |
Free Cash Flow | -95,695 | -100,992 | -79,045 | -57,498 |
Cash | 74,015 | 155,384 | 119,136 | 154,744 |
Basic Shares | 19,884 | 8,512 | 7,118 | 3,462 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.61 |
2024-03-31 | -$0.64 |
2023-12-31 | -$1 |
2023-09-30 | -$1.05 |
